4//SEC Filing
Doberstein Stephen K 4
Accession 0001209191-19-048922
CIK 0000906709other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 5:09 PM ET
Size
5.2 KB
Accession
0001209191-19-048922
Insider Transaction Report
Form 4
Doberstein Stephen K
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2019-09-05$17.28/sh+15,000$259,200→ 107,668 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $17.18 to $17.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001480111
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 5:09 PM ET
- Size
- 5.2 KB